MORE►
UT Southwestern Medical Center
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
by Quincy Preston |
Feb 20, 2025
The new center at Bridge Labs will train the workforce powering North Texas’ biotech boom—helping startups speed therapies, vaccines, and breakthrough biologics from lab bench to patients. Funded in part by Lyda Hill Philanthropies, the National Center for Therapeutics Manufacturing Satellite Campus is set to open this summer.
MORE►
by Lance Murray |
Feb 14, 2025
A clinical trial led by researchers at UT Southwestern Medical Center in Dallas could help bring an experimental treatment for depression closer to approval from the U.S....
MORE►
by Lance Murray |
Feb 5, 2025
Dr. Kirk Calhoun was named interim president following the resignation in January of UNTHSC President Sylvia Trent-Adams.
MORE►
Rendering of Children’s Health and UT Southwestern's new pediatric campus [Image: Children’s Health]
Children’s Health, UTSW Break Ground on $5B Dallas Pediatric Campus, Announce $100M Donation from Rees‑Jones Foundation
by Lance Murray | Oct 2, 2024
Children's Health and UT Soutwestern announced that a $100 million gift from The Rees-Jones Foundation will support the construction of the new pediatric campus, just months after the Jean and Mack Pogue family gave its own $100 million gift. This marks the first time in Texas that a not-for-profit construction project has received two individual leadership gifts of $100 million.
MORE►
by Quincy Preston |
Aug 9, 2024
With a new CEO and three seasoned industry veterans joining its board, Research Bridge Partners is focused on moving university innovations from the lab to the marketplace.
Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
MORE►
by Lance Murray |
Jul 17, 2024
Researchers at UT Southwestern Medical Center in Dallas have identified a compound that selectively eliminates cancer cells while sparing immune cells in a form of cell death known as ferroptosis, according to a news release.
UTSW said the findings, published in Science Translational Medicine earlier this year, could lead to new treatments for a wide variety of cancer types....
MORE►
by Lance Murray |
Jun 17, 2024
Researchers at Children's Hospital of Philadelphia and UT Southwestern analyzed T-cell receptors in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer. The results point to the potential of testing for biomarkers 2 to 4 years before most cases of HGOC are currently diagnosed.
MORE►
ImmuneSensor Therapeutics President and CEO Tom Dubensky [Photo: ImmuneSensor Therapeutics]
ImmuneSensor Therapeutics Announces New President/CEO
by Lance Murray | May 3, 2024
Thomas W. Dubensky Jr., Ph.D., is a veteran biopharma executive and entrepreneur with a track record of strategic leadership in both private and public companies, ImmuneSensor said.
MORE►
by Glenn Hunter |
May 2, 2024
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
MORE►
![Clockwise from left: Andrew Denton, Anisha Holla, Ralph Yongoueth, Ananya Sammidi, Asad Moulvi, Sahil Patel, and Rick Tett will pitch in UT Dallas' Big Idea Competition 2024 student and alumni track finals on April 17. [Photos via UT Dallas and the entrepreneurs; Graphics: DI Studio, istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2024/04/UTD-Big-Ideas-Student-Alumni-Track-BIC2024-360x203.jpg)
by Quincy Preston |
Apr 4, 2024
The University of Texas at Dallas' largest startup pitch event, now in its 17th year, isn't sitting on its laurels. Here's what's new this year, and who made the finals. With dual events, a fireside chat, and judge-powered prize allocations, it's set to unfold on April 5 and 17.
MORE►
by Lance Murray |
Mar 6, 2024
With support from the American Heart Association, Access TeleCare and UT Southwestern Medical Center are spearheading a two-year initiative aimed at improving cardiac care for rural patients.
MORE►
UT Southwestern's Clements University Hospital [Photo: UTSW]
CPRIT Approves Over $16M in Cancer-Fighting Grants to Dallas-Area Institutions
by Lance Murray | Feb 27, 2024
Included in the 12 Dallas-area funding awards is a $4 million Rising Star grant to bring Stefan Gloeggler, Ph.D., to UT Southwestern Medical Center from the Max Planck Institute of Multidisciplinary Sciences in Göttingen, Germany.
MORE►
by Lance Murray |
Feb 13, 2024
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
MORE►
by Lance Murray |
Feb 7, 2024
The new campus in Dallas' Southwestern Medical District will "enhance our shared capacity to provide comprehensive care for children, including those with the most complex medical and surgical needs," said Christopher Durovich, president and CEO of Children's Health.
MORE►
by Lance Murray |
Jan 15, 2024
Molecular biologist Vincent Tagliabracci, who was named a Howard Hughes Medical Institute Investigator in 2021, will be honored by the Texas Academy of Medicine, Engineering, Science and Technology for his groundbreaking work on so-called zombie enzymes.
MORE►
